Skip to content
Search

Latest Stories

New report reveals small rise in NHS dental workforce in England

New report reveals small rise in NHS dental workforce in England

More than 30 million courses of dental treatment were delivered in 2023/24 in England  

A new report published by the NHS Business Services Authority (NHSBSA) reveals that 24,300 dentists performed NHS dental activity in England in 2023/24, marking a 0.4 per cent rise from the previous year’s 24,227.

However, this figure represents a 1.5 per cent decrease from 24,700 dentists with NHS activity in 2019/20.


The report covers NHS dental activity and the NHS dental workforce in England from 2019/20 to 2023/24.

It is the first release from NHSBSA following the transition from NHS England, which previously issued the report.

There were 34 million courses of dental treatment in England for 2023/24, a 4.3 per cent increase from 2022/23. The total units of dental activity (UDAs) rose by 3.4 per cent to 73 million.

Other key findings include:

  • There were 18 million adult patients seen in the 24 months up to the end of March 2024
  • There were 6.7 million child patients seen in the 12 months up to the end of March 2024
  • Courses of treatment for adults increased by 2.2 per cent to 23 million, while those for children rose by 9.0 per cent to 11.2 million.
  • Among child treatment courses, more than 56 per cent included fluoride varnish.

The total number of units of dental activity awarded to dental activity claims was 72.5 million in 2023/24, reflecting a 3.4 per cent increase from the previous year but a 9.1 per cent decrease from the 79.7 million UDAs in 2019/20.

Total revenue from patient charges amounted to £774 million in 2023/24, a 2.7 per cent increase from £754 million the previous year.

In February 2024, the previous government introduced the NHS dental recovery plan, backed by £200 million in funding. The plan was designed to provide over 1.5 million additional NHS dental treatments or up to 2.5 million NHS dental appointments within the next 12 months.

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less